Patent · US Active

Enantiomeric pure β agonists, manufacturing and use as a medicament thereof

US7534789B2 · kind B2 · utility

1Cited by

4References

18Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Uwe Ries · Biberach an der Riß, DE
Peter Sieger · Mittelbiberach, DE

Key dates

Filing date	Mar 15, 2007
Grant date	May 19, 2009
Priority date	—
Expiry date	Mar 15, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to enantiomerically pure compounds of formula 1wherein the groups m, n, B, X, R1, m and Ym− may have the meanings given in the claims and specification, methods for preparing them and their use as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.